- LSD at doses of 20 µg significantly increased pain tolerance and diminished subjective pain levels among participants.
- The study suggests that low-dose LSD can serve as a potential analgesic without inducing profound psychedelic experiences.
- Increased blood pressure was observed during LSD treatment, but it did not adversely affect heart rate or temperature.
Introduction to the Study
The research presented is part of a four-part investigation involving 24 participants, aimed at examining the effects of microdoses of LSD (5-20µg) across various factors including mood and pain tolerance. Findings from this initial phase indicate that administering LSD increases participants’ tolerance to pain, specifically assessed through standardized tests.
Background and Context
LSD, or lysergic acid diethylamide, is a psychedelic compound made from an ergot alkaloid, historically utilized for its analgesic properties, particularly during the 1960s and 1970s in terminally ill patients. However, research into its medical potential halted due to its worldwide scheduling as a controlled substance. This current study aims to re-examine LSD’s potential as an analgesic but at doses that avoid significant mind-altering effects.
Methodology
Conducted with 24 healthy subjects, the study administered oral doses of 5, 10, and 20 µg of LSD on separate occasions, with a placebo as a control. The Cold Pressor Test (CPT), which immerses the hand in cold water to induce pain, was performed at intervals post-administration to measure pain tolerance along with assessments of mental status and vital signs to ensure participant safety. Participants were young adults with prior psychedelic experiences, ensuring a level of comfort with the substances being tested.
Results Overview
The study’s results demonstrated that the 20 µg LSD dose significantly enhanced pain tolerance and decreased reported levels of pain and discomfort with the cold water test. In contrast, the lower doses did not yield statistically significant alterations in pain perception. The researchers observed slight increases in blood pressure and mild dissociative symptoms related to the higher dose, indicating potential psychological effects that did not extend to serious adverse effects like heart rate changes.
Discussion and Implications
This study uncovers a noteworthy potential for low-dose LSD in pain management. The analgesic effects were comparable to traditional pain relief methods, such as opioids, although with significantly lower side effects. The sustained effects of LSD on pain tolerance, observed even hours after administration, suggest that it could be useful in chronic pain therapies and serve as an alternative to current pain management paradigms that often rely on opioids and other drugs with varied risks of side effects and dependency.
The mechanism through which LSD may alleviate pain requires additional investigation. Potential theories include its impact on neurotransmitter activity involved in pain processing and coping strategies, or through physiological pathways like enhancing self-transcendence similar to meditation practices. Overall, the findings warrant further exploration into low-dose LSD as a burgeoning avenue for addressing chronic pain without the complications associated with existing treatments.
Read the full paper summary on Blossom.
